Macclesfield, United Kingdom

David Waterson

This inventor holds 31 USPTO granted patents and 1 published patent application and 2 EPO patents, primarily in Metalloproteinase Inhibitors. Top assignees: Imperial Chemical Industries Limited, Ici Pharma, Astrazeneca Ab. Active years: 1992-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Waterson. Retrieved from https://idiyas.com/inventor/david-waterson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 

% Patents Active = 71.0

 

Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 231(Granted Patents)


Location History:

  • Bollington, GB (1992 - 1996)
  • Cheshire, GB (1993 - 2014)
  • Nyon, CH (2016)
  • Macclesfield, GB (1992 - 2019)

Company Filing History:


Years Active: 1992-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
Anti-Malarial Agents
Metalloproteinase Inhibitors
Heterocyclic Compounds
Pyran Derivatives
Arylpiperazines
Sulphonamide Derivatives
Pharmaceutical Agents
Optically Active Compounds
Bicyclic Derivatives
Cholesterol Inhibitors
5-Lipoxygenase
Crystalline Salts
31 patents (USPTO):Explore Patents

Title: David Waterson - Innovator in Anti-Malarial Research

Introduction

David Waterson is a renowned inventor based in Macclesfield, GB, recognized for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 31 patents, Waterson has dedicated his career to the development of innovative solutions, particularly in the area of anti-malarial agents.

Latest Patents

Among his latest inventions, Waterson focuses on the use of aminopyrazine derivatives in manufacturing medicaments for preventing or treating malaria. His patents encompass formulations designed to inhibit malaria parasite proliferation, showcasing the potential of aminopyrazine derivatives in pharmaceutical applications. The latest patents demonstrate a commitment to advancing medical science and combating one of the world's leading health challenges.

Career Highlights

Throughout his career, Waterson has worked with notable companies, including Imperial Chemical Industries Limited and ICI Pharma. His experiences with these organizations reflect a strong foundation in chemical and pharmaceutical research, where he has had the opportunity to innovate and develop groundbreaking treatments.

Collaborations

David Waterson has collaborated with fellow researchers such as Nicholas John Newcombe and Howard Tucker. These partnerships emphasize the importance of teamwork in scientific research and the continuous drive toward medical innovation.

Conclusion

David Waterson stands out as a prominent inventor, whose work in anti-malarial agents exemplifies the intersection of creativity and scientific inquiry. His ongoing contributions not only enrich medical literature but also offer hope in the fight against malaria, illustrating the vital role of inventors in society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…